Literature DB >> 559402

Measles as a cause of fetal defects. A retrospective study of tem measles epidemics in Greenland.

C S Jespersen, J Lttauer, U Sagild.   

Abstract

In a retrospective study of ten epidemics of measles in virgin-soil populations in Greenland, 368 women were found to be pregnant at the time of their infection with measles. Information on the course of the pregnancies was obtained in 327 of these women and a clinical examination was made of 252 of their children. The risk of fetal death among women infected in the first trimester was found to be high. About half of 20 women infected during their first two months of pregnancy and a fifth of 31 women infected in the third month had abortions. 9% of 64 women infected in the first trimester and going to term had stillbirths. 28 women infected in the first two months of pregnancy had live children, but four of these had congenital malformations, three of extreme rarity and severity, leading to death. The rate of perinatal mortality and prematurity was equal among infants exposed to measles in the first, second and third trimester of fetal life.

Entities:  

Mesh:

Year:  1977        PMID: 559402     DOI: 10.1111/j.1651-2227.1977.tb07909.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Editorial commentary: Measles in pregnancy is not child's play.

Authors:  Philip Alfred Brunell
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

Review 2.  What Obstetric Health Care Providers Need to Know About Measles and Pregnancy.

Authors:  Sonja A Rasmussen; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

3.  Scandinavian model for eliminating measles, mumps, and rubella.

Authors:  E Rabo; J Taranger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

Review 4.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.